Perimenopause & Menopause — Suicide‑Risk Facts
Around 16.6% of women in perimenopause/menopause report suicidal thoughts when they first seek help.
UK suicide deaths in women peak at ages 45–54, which is the menopause window.
Most research (about 84% of studies) finds a clear link between hormonal instability in perimenopause and increased suicidal thinking.
The risk is highest during perimenopause, when hormones fluctuate sharply. Then factor in Diagnosed/ Not Diagnosed Neurodivergence - if you didn't know/Perimenopause heightens everything.
Suicidal thoughts often do not show up on standard depression questionnaires, meaning many women are missed.
Emotional instability in this phase is biological, not character‑based — driven by rapid changes in oestrogen and progesterone sensitivity.
PMDD — Prevalence & Risk Facts (25 and over)
The best-confirmed global prevalence of PMDD is 1.6% (strict DSM‑5 criteria).
What “1.6% confirmed PMDD” really means
The 1.6% figure comes from the most rigorous type of research: women who met every single DSM‑5 diagnostic requirement, tracked over multiple cycles, with symptoms verified by clinicians.
To be counted in that 1.6%, a woman must have:
symptoms only in the luteal phase
symptoms that stop when her period starts
symptoms severe enough to disrupt daily life
symptoms tracked for at least two cycles
no other condition explaining the pattern
a clinician confirming the diagnosis
Because the criteria are so strict, this number represents the minimum, not the true total.
It’s like counting only the women who made it through every locked door in a long corridor — while thousands more are stuck at the doors labelled misdiagnosed, dismissed, not tracked, not believed, no specialist available, no cycle charting, crisis before diagnosis.
So:
1.6% = the women who were fully recognised. Not the women who actually suffer with PMDD.
A further 3.2% have suspected PMDD without full cycle tracking.
Broader estimates range 3–8% depending on how the study measures symptoms.
PMDD affects women mostly between 18–55, so the statistics apply directly to women over 25.
PMDD is strongly associated with suicidal thoughts, even in the strict 1.6% group.
Symptoms often worsen in the late 30s–40s, and PMDD can become more volatile as women approach perimenopause.
PMDD is a brain-based sensitivity to progesterone, not a mood disorder caused by life events.
A common trait seen in PMDD is that many women reach crisis point long before they ever receive a diagnosis. Because PMDD is so often missed, dismissed, or mislabelled, a significant number of women who die by suicide are never formally diagnosed, which means the true statistics are almost certainly higher than the confirmed numbers. This diagnostic gap makes it extremely difficult for researchers to capture the real scale of PMDD‑related suicide risk.
Comments
Post a Comment